Indications |
Oral Peptic ulcer, Gastritis Adult: 100 mg tid. |
Mechanism of Actions |
Troxipide has cytoprotective properties on the gastric mucosa. It has been postulated that troxipide's mucosal protective effect in gastric ulcer and gastritis is exerted via the inhibition of inflammatory responses and neutrophil-mediated mucosal injury. As neutrophils are thought to be involved in the pathogenesis of H. pylori-mediated mucosal injury, it is plausible that troxipide may also be able to mediate gastric mucosal damage due to H. pylori. |
ATC Classification |
A02BX11 - troxipide ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD). |
Available As |
|
Troxipide
Post Review about Troxipide Click here to cancel reply.
Troxipide Containing Brands
Troxipide is used in following diseases
Drug - Drug Interactions of Troxipide
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.